CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP & Chief Legal Officer sold 49,941 shares at an average $19.10 ($953,975)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chairman & CEO sold 33,115 shares at $20.00 ($662,300)
- 4 Exercise or conversion SVP & Chief Medical Officer acquired 12,000 shares (option exercise)
- 4 Open-market sale SVP & Chief Medical Officer sold 32,280 shares at an average $18.48 ($596,487)
- 4 Open-market sale EVP & Chief Legal Officer sold 59 shares at $18.58 ($1,096)
- 4 Open-market sale SVP & Chief Medical Officer sold 11,316 shares at an average $18.29 ($207,011)
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion SVP & Chief Medical Officer acquired 8,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion SVP & Chief Medical Officer acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
Page 17 of 20 · 386 filings